mylan planning strategic review of its business
Published 6 years ago • 265 plays • Length 2:32
Download video MP4
Download video MP3
Similar videos
-
1:46
mylan ceo to depart as part of deal with pfizer's off-patent drug business
-
3:58
mylan meets with investors to communicate benefits of pfizer merger
-
3:06
mylan, pfizer combined could generate more than $19 billion in annual sales: analyst
-
4:29
mylan drug pricing hearing | squawk box | cnbc
-
2:50
pfizer to combine off-patent drug business with mylan
-
3:32
final trades: mylan, overstock & homebuilders
-
0:49
mylan stock up after positive earnings report
-
4:42
pfizer to merge off-patent drug business with mylan
-
58:42
creating a technology strategy and roadmap for global manufacturing at merck
-
5:28
nyc takes mylan to task over epipen price hikes | squawk box | cnbc
-
3:58
bill george: heather bresch should commit to no further price increases | power lunch | cnbc
-
1:45
mylan, servicenow, factset & biotech
-
4:22
mylan to launch generic epipen at 50% discount | squawk box | cnbc
-
2:28
mylan ceo: congress needs to fix outdated health care system | squawk box | cnbc
-
2:24
mylan soars on epipen settlement | power lunch | cnbc
-
1:01
mylan, servicenow, factset & biotech
-
2:31
health-care m&a takes center stage with mylan-pfizer, exact-genomic deals
-
7:11
mylan ceo on fda-approved biosimilar, trump's drug price plan
-
1:14
mylan, puma technology, servicenow, alphabet & the tech sector
-
1:51
senator grassley: mylan's epipen inquiry response 'incomplete' | power lunch | cnbc
-
2:45
phizer buys mylan after stock drop
-
2:44
mylan: generic, cheaper version of epipen on the way
Clip.africa.com - Privacy-policy